Skip Navigation

Pharmacy Residency Programs

  • pharmacy residents

  • The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases.

    The Pharmacy department maintains programs and practices to ensure safe, optimal, and cost effective drug therapy for Dana-Farber patients, while also supporting patient and provider drug education and patient care-oriented research.

  • About the Pharmacy Residency Programs

    Dana-Farber Cancer Institute is proud to offer three ASHP-accredited Post-Graduate Year 2 (PGY-2) Pharmacy Residency Programs:

    • Oncology Pharmacy Residency (Onc) – 2 positions
    • Pain Management/Palliative Care Pharmacy Residency (PMPC) – 1 position
    • Medication-Use Safety (MUS) (ASHP Candidate) – 1 position

    These positions are designed to provide the resident with opportunities to develop clinical competence in pharmacy practice. Residents are exposed to a multitude of experiences related to patient care, involving both inpatient care and ambulatory-related experiences.

    Pharmacy resident benefits

    Pharmacy residents will receive a competitive stipend for the PGY-2 residency year. Other benefits include, but are not limited to, medical and dental coverage, and MBTA discount passes. In addition, there is conference fee and travel compensation available for residents to attend up to 2 national and 2 local conferences, including the ASHP Mid-Year Meeting.

      Holidays

      New Year’s Day, Martin Luther King Day, President’s Day, Memorial Day, Independence Day, Labor Day, Columbus Day, Thanksgiving Day, and Christmas Day are all observed holidays.

      Vacation days

      Residents are entitled to 10 days of vacation. Vacation days are to be approved by the residency director and sufficient notice given.

    • Oncology Pharmacy Residency (Onc)

      The Dana-Farber Cancer Institute (DFCI) PGY2 Oncology Pharmacy Residency is a 1-year postgraduate educational and training experience designed to develop advanced knowledge, skills, and leadership in the delivery of pharmaceutical services to patients with cancer. Residents who successfully complete a PGY2 oncology pharmacy residency at Dana-Farber will be prepared to become proficient clinical oncology pharmacy practitioners, educators, and leaders.

      Residents in the Oncology Pharmacy Residency will gain experience in a variety of areas of clinical oncology practice, including inpatient and outpatient adult solid tumor and hematologic malignancies, palliative care, pediatric oncology, ambulatory infusion pharmacy, and investigational drug services. In addition to providing direct patient care, residents are involved in various educational, administrative, and research projects.

      Through these educational experiences, residents will:

      • Demonstrate development as a role model for clinical pharmacists in the oncology setting.
      • Develop skills in pharmacy administration, disease state management, drug information, synthesis and analysis of clinical information, and development of clinical care plans.
      • Develop various teaching styles for applicatio in a variety of settings, including experiential education, small group teaching, and group lecture.
      • Collaborate with clinical pharmacy staff to provide educational resources for patients and practitioners.
      • Refine communication and time management skills.
      • Develop, implement, and analyze data of a year-long, publishable research project.
      • Incorporate self-directed learning and personal development through self-reflection, evaluation, and feedback.

      Oncology Pharmacy Learning Experiences

      Core Clinical Learning Experiences

      • Orientation (2 weeks)
      • Ambulatory oncology infusion pharmacy (4 weeks)
      • Ambulatory oncology (3 x 4-week experiences)
      • Medical oncology (inpatient, 4 weeks)
      • Hematologic oncology (inpatient, 6 weeks)
      • Palliative care (inpatient, 4 weeks)
      • Stem cell transplant (inpatient, 4 weeks)
      • Pediatric oncology (ambulatory, 4 weeks)
      • Investigational drug service (ambulatory, 2 weeks)

      Longitudinal Learning Experiences

      • Medication safety (3 months)
      • Pharmacy administration (10 months)
      • Oral chemotherapy teach (10 months)
      • Weekly oncology topic discussions (12 months)
      • Academia (10 months) (Certificate programs available for those interested)
      • Research (12 months)

      Elective Learning Experiences

      Four weeks of the year are dedicated to an elective based on resident interest. They may choose to repeat a core rotation (listed below) or pursue a different area of interest.

      • Medical Oncology II
      • Hematologic Oncology II
      • Ambulatory Oncology II
      • Palliative Care II
      • Inpatient CAR-T Cell Therapy

      Residency Learning Experiences/Educational Activities

      Research project

      Research projects will be determined according to the resident's interest and departmental needs. The resident is required to complete one project and present a poster at the HOPA (Hematology/Oncology Pharmacy Association) annual conference. The resident will also prepare a finished manuscript suitable for publication by the end of the residency year.

      Examples of past resident research projects include:

      • Evaluation of Infusion Reactions in Patients Receiving Daratumumab Post-Implementation of an Augmented Pre- and Peri-medication regimen (accepted ASH poster presentation, 2018)
      • Evaluation of Re-intensification of Daratumumab to Weekly or Biweekly Dosing Schedule (accepted ASH poster presentation, 2018)
      • Differentiation Syndrome in Patients Based on Timing of Initial All-Trans Retinoic Acid Administration (accepted ASH poster presentation, Dec 2017)
      • Evaluation of Thromboembolic Events in Patients Receiving Direct Oral Anticoagulation Therapy (accepted ASH poster presentation, Dec 2017)

      Medication Use Evaluations (MUEs)

      Residents may choose to complete a MUE during the first half of the year to present by poster at the ASHP Midyear Meeting. Residents are presented with MUE topics at the start of the residency year and may collaborate on one MUE or choose separate MUEs.

      Continuing Education (CE) Programs

      Dana-Farber’s Department of Pharmacy is approved by the Accreditation Council for Pharmacy Education (ACPE) to offer continuing education programs for pharmacists and technicians. Residents are required to provide one ACPE-accredited CE presentation during the residency year (Fall, Winter or Spring).

      Didactic Lectures

      Dana-Farber’s PGY-2 Oncology Pharmacy Residency gives residents opportunities to lecture students at MCPHS University – Boston. Residents are expected to present two lectures (Winter/Spring) for the oncology elective at MCPHS University. Residents co-present an assigned topic in the winter and present a topic of their choice in the spring.

      Precepting Experience

      Residents are provided with opportunities to co-precept students affiliated with Northeastern School of Pharmacy and MCPHS University during their inpatient Medical Oncology and Palliative Care learning experiences.

    • Pain Management/Palliative Care Pharmacy Residency (PMPC)

      The Dana-Farber Cancer Institute PGY-2 Pain Management and Palliative Care Pharmacy Residency is designed to provide the resident with opportunities to develop clinical competence in pain management and palliative care in various settings.

      The PGY-2 Pain Management and Palliative Care Pharmacy resident will gain experience in the following areas of practice: inpatient and outpatient palliative care, hospice, inpatient and outpatient specialized pain management, and pain management in the primary care setting. Primary rotation sites include: Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and MCPHS University.

      Didactic and experiential learning is enhanced through the Harvard Interprofessional Palliative Care Fellowship Program, which provides the only opportunity nationally for a pharmacy resident to join a fellowship with medical, nursing, and social work fellows in both adult and pediatric palliative care. The pharmacy resident is fully integrated into this fellowship program, which offers didactic and experiential learning geared toward the health care professional working with an interdisciplinary team.

      Throughout these experiences a resident completing the program will be able to:

      • Demonstrate development as a role model for clinical pharmacists in the pain management and palliative care setting.
      • Develop various teaching styles and approaches for application in a variety of settings, including experiential education, small group teaching, and group lecture.
      • Collaborate with clinical pharmacy staff to provide educational resources for patients and practitioners.
      • Develop skills in the areas of pharmacy administration, disease state management, drug information, synthesis and analysis of clinical information, and development of clinical care plans.
      • Refine communication and time management skills.
      • Develop, implement and analyze data of a yearlong, publishable research project.
      • Incorporate self-directed learning and personal development through self-reflection, evaluation, and feedback.

      Pain Management/Palliative Care Learning Experiences

      Core Clinical Learning Experiences

      • Orientation (2 weeks)
      • Intensive Palliative Care Unit (6 weeks)
      • Hospice (4 weeks)
      • Inpatient Palliative Care Consult Team (6 weeks)
      • Ambulatory pain management (12 weeks)
      • Academia (12 weeks concurrent with Ambulatory Pain Management)
      • Post-Operative Pain Management Service (2 weeks)

      Longitudinal Learning Experiences

      • Outpatient Palliative Care Clinic (16 weeks)
      • Harvard Interprofessional Palliative Care Fellowship (12 months)
      • Residency Project (past project example: Improving Accuracy of PCA Documentation in EPIC at MGH)
      • Outpatient Pharmacy Department (12 months)
      • Medication-Use Management (9 months)

      Elective Learning Experience Opportunities

      • Palliative Care Clinic II
      • Hospice II
      • Palliative Care Consult II
      • Intensive Palliative Care Unit II
    • Medication-Use Safety (MS)

      By actively participating in medication error, pharmacy intervention, and adverse drug event reporting processes, the PGY2 Medication-Use Safety Pharmacy Resident will gain experience in medication safety assessment, as well as quality and process improvement. The resident will participate in several medication safety-related activities, such as root cause analyses, system assessments, and quality/process improvement projects. 

      The resident will also lead the interdisciplinary pharmacy intervention subcommittee; serve as a member of the ambulatory event committee and pharmacy and therapeutics committee; and will partake in various clinical informatics workgroups. Other activities may include conducting pharmacy safety rounds, policy and guideline development, and workflow development and implementation – all while promoting a culture of safety within the department and across the Institute. The resident will foster these skills in the outpatient, inpatient, adult, and pediatric settings.

      The resident will work closely with other interdisciplinary departments, including the Center of Patient Safety, Risk Management, Quality/Process Improvement, Clinical Informatics, and others.

      The fundamental goal of the residency is to provide training so that pharmacists develop excellent knowledge in the principles of medication-use safety; communication and leadership; and strategies to collect, analyze, and implement changes to clinical and operational processes that promote safe medication-use practices.

      Throughout these experiences, a resident completing the program will be able to:

      • Understand and utilize methods to promote safety
      • Provide comprehensive evaluation of medication events and participate in the development and implementation of mitigation strategies
      • Review, analyze, and categorize near-miss medication reports; identify patterns necessitating further evaluation; and lead efforts to develop improvement strategies
      • Utilize data provided by technology to analyze medication-use practice; participate in the implementation of technologies that promote safety medication-use practices
      • Participate in the analysis and mitigation of medication-use system issues due to changes in USP800, technology, communication issues, or other factors as they arise
      • Analyze and understand complex systems and human factors to implement solutions that minimize medication safety gaps
      • Participate and lead committees and efforts that promote medication safety
      • Complete a longitudinal research project that improves the quality and safety of the medication-use process

      Core Clinical Learning Experiences

      • Principles of Medication Safety
      • Ambulatory/Inpatient Medication Safety 
      • Pharmacy Intervention
      • Clinical Informatics
      • Pharmacy Operations
      • Quality/Process Improvement

      Longitudinal Learning Experiences

      • Pharmacy Intervention Subcommittee
      • Ambulatory Event Subcommittee
      • Quality and Patient Safety Huddle
      • Pharmacy and Therapeutics Committee
      • Residency Research Project
      • Staffing responsibilities in the Dana-Farber Ambulatory Infusion Clinics
    • Residency Program Director, Pain Management/Palliative Care Pharmacy Residency

      Bridget Fowler Scullion, PharmD, BCOP
      Director, Clinical Pharmacy Services
      Education: St. Louis College of Pharmacy
      Palliative Care Residency: University of Maryland, School of Pharmacy, Baltimore, MD
      Precepts: Outpatient Palliative Care, Inpatient Palliative Care Consults, Harvard Interprofessional Palliative Care Fellowship, Residency Project (PMPC)

      Residency Program Director, Oncology

      Hillary A. Prescott, PharmD, BCOP
      Manager, Clinical Pharmacy Services
      Clinical Specialist, Lymphoma
      Education: University of Rhode Island, Providence, RI
      PGY-1: Virginia Commonwealth University Health System/Medical College of Virginia Hospitals, Richmond, VA
      PGY-2 Oncology: University of North Carolina Hospitals, Chapel Hill, NC
      Precepts: Ambulatory Oncology (Lymphoma)

      Residency Program Director, Medication-Use Safety

      Audrea Szabatura, PharmD, BCOP
      Medication Safety Officer
      Education: University of Connecticut
      PGY-1: Thomas Jefferson University Hospital, Philadelphia, PA
      PGY-2 Oncology: The Johns Hopkins Hospital, Baltimore, MD
      Precepts: Medication Safety, Oral Chemotherapy Teach (Onc)

    • Preceptors

      Sylvia B. Bartel, RPh, MHP
      Vice President of Pharmacy Services
      Education: University of Wisconsin, Madison, WI
      PGY-1: National Institutes of Health, Clinical Center, Bethesda, MD
      Precepts: Administration (Onc)

      Christy S. Harris, PharmD, BCPS, BCOP
      Associate Professor, MCPHS University, Clinical Pharmacy Specialist
      Education: University of Tennessee Health Sciences, Memphis, TN
      PGY-1: University of Tennessee Medical Center, Knoxville, TN
      PGY-2 Oncology: Medical University of South Carolina, Charleston, SC
      Precepts: Academia (Onc)

      Michele Matthews, PharmD, CPE, BCACP, FASHP
      Associate Professor of Pharmacy Practice, MCPHS University
      Advance Practice Pharmacist, Pain Management, Brigham and Women's Hospital, Boston, MA
      Education: MCPHS University, Boston, MA
      PGY-1: Robert Wood Johnson Hospital, New Brunswick, NJ
      Precepts: Ambulatory Pain Management (PMPC), Academia (PMPC)

      Houry Leblebjian, PharmD, BCOP
      Clinical Pharmacy Practice Administrator
      Education: Lebanese American University, West Beirut, Lebanon
      PGY-1: UMass Memorial Medical Center, Worcester, MA
      PGY-2 Oncology: Dana-Farber Cancer Institute, Boston, MA
      Precepts: Ambulatory Oncology-Myeloma (Onc)

      Andrew Skirvin, BS, PharmD, BCOP
      Associate Clinical Professor, Northeastern University, Hematology/Oncology Clinical Pharmacist
      Education: University of Texas Health Science Center (PharmD) and Oregon State University (BS)
      PGY-2 Oncology Specialty Pharmacy: Audie L. Murphy Memorial VA Hospital, San Antonio, TX
      Precepts: Medical Oncology (Onc)

      Victor Phantumvanit, PharmD, BCPS, BCOP
      Clinical Pharmacy Specialist - Palliative Care
      Education: University of Maryland, School of Pharmacy, Baltimore, MD
      PGY-1: Central Washington Hospital, Wenatchee, WA
      PGY-2 Oncology & Palliative Care: Dana-Farber Cancer Institute, Boston, MA
      Precepts: Inpatient Palliative Care (Onc and PMPC)

      Marina Kaymakcalan, PharmD, BCOP
      Clinical Pharmacy Specialist
      Education: Massachusetts College of Pharmacy and Health Science (MCHPS)
      Precepts: Ambulatory Oncology - Genitourinary (Onc)

      Phuong Nguyen, PharmD
      Outpatient Pharmacy Manager
      Education: MCPHS University, Boston, MA
      Precepts: Outpatient Pharmacy Department (PMPC)

      Inna Zinger, NP, AGPCNP-BC
      Adult Nurse Practitioner, Post-Operative Pain Service, Brigham and Women's Hospital
      Education: BSN, Northeastern University, Boston, MA; MSN, Northeastern University, Boston, MA
      Precepts: Post-Operative Pain Management Service (PMPC)

      Benjamin S. Kematick, PharmD, BCACP
      Clinical Pharmacy Specialist - Palliative Care
      PGY-1: University at Buffalo/Mobile Pharmacy Solutions, Buffalo, NY
      PGY-2: Dana-Farber Cancer Institute, Boston, MA
      Education: University at Buffalo, Buffalo, NY
      Precepts: Ambulatory Palliative Care (PMPC)

      Mary Nauffal, PharmD, MS, BCOP
      Hematology/Oncology Clinical Pharmacy Specialist, Brigham and Women's Hospital
      PGY-1: Brigham and Women's Hospital, Boston, MA
      PGY-2: Dana-Farber Cancer Institute, Boston, MA
      Education: Lebanese American University, Beirut, Lebanon
      Precepts: Hematologic Malignancies and Bone Marrow Transplant (Onc)

      Patrick McBridge, PharmD, BCOP
      Oncology Clinical Pharmacist (Pediatrics)
      PGY-1: Children's Hospital of Wisconsin, Milwaukee, WI
      PGY-2: Dana-Farber Cancer Institute, Boston, MA
      Education: MCPHS University, Boston, MA
      Precepts: Pediatric Oncology (Onc)

      Jiale Dai, PhD, RPh
      Director of Research Pharmacy
      Fellowship: The John Hopkins Oncology Center, Baltimore, MD
      Education: Fu Dan University School of Pharmacy, Shanghai, China
      PhD: University of Miami School of Medicine, Miami, FL
      Precepts: Investigational Drug Service (Onc)

      Alifia Waliji-Banglawala, PharmD
      Director of Pharmacy, Care Dimensions Hospice and Palliative Care, Waltham, MA
      Affiliate Assistant Clinical Professor, Northeastern University Bouve College of Pharmacy
      PGY-1: Tampa General Hospital
      Education: University of Florida, Gainesville, FL
      Precepts: Hospice (PMPC)

      Kareem Abdalla, PharmD
      Clinical Informatics Pharmacist
      Masters of Biomedical Informatics Candidate (2021), Harvard Medical School, Boston, MA
      Education: University of Rhode Island, Kingston, RI
      Precepts: Medication Safety - Information Systems

      Teresa Ryan, PharmD, BCOP
      Oncology Research Pharmacist
      Education: Massachusetts College of Pharmacy and Health Sciences
      Precepts: Investigational Drug Service (Onc)

    • Current and Past Residents

      Current Residents

      Oncology

      Eno-Abasi Inyang, PharmD, BCPS
      PGY-1 Training: St. Joseph Medical Center, Tacoma, Washington
      Education: University of Southern California, Los Angeles, California

      Shawn Streeter, PharmD
      PGY-1 Training: Riverside University Health System, Moreno Valley, California
      Education: University of North Carolina Eshleman School of Pharmacy, Chapel Hill, North Carolina

      Pain Management/Palliative Care

      Annabelle Hood, PharmD
      PGY-1 Training: University of Charleston School of Pharmacy, Charleston, West Virginia
      Education: MCPHS University, Boston, MA

      Medication-Use Safety

      Grace Hwang, PharmD
      PGY-1 Training: Houston Methodist Hospital, Houston, Texas
      Education: University of Houston College of Pharmacy, Houston, Texas

      Past Residents

      2018-2019

      Oncology

      Megan Duperreault, PharmD
      PGY-1 Training: Brigham and Women's Hospital, Boston, MA
      Education: South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, SC
      Current Position: Clinical Oncology Pharmacist – Hematology, Maine Medical Center, Portland, Maine

      Erin Grannan, PharmD
      PGY-1 Training: MedStar Washington Hospital Center, Washington, DC
      Education: Philadelphia College of Pharmacy at the University of the Sciences, Philadelphia, PA
      Current Position: Clinical Pharmacy Specialist - Medical Breast Oncology, MD Anderson Cancer Center, Houston, TX

      Pain Management/Palliative Care

      Mara Hofherr, PharmD
      PGY-1 Training: Christian Hospital, St. Louis, MO
      Education: Saint Louis College of Pharmacy, St. Louis, MO
      Current Position: Oncology Clinical Pharmacist, Delbert Day Cancer Center, Rolla, Missouri

      Medication-Use Safety

      Garrett Rompelman, PharmD
      PGY-1 Training: Community Healthcare System - Community Hospital, Munster, IN
      Education: University of Illinois at Chicago College of Pharmacy, Chicago, IL
      Current Position: Clinical Infusion Pharmacist, Dana- Farber Cancer Institute, Boston, MA

      2017-2018

      Oncology

      Elaine Xiang, PharmD, BCOP     
      PGY-1 Training: NYU Langone Medical Center, New York, NY     
      Education: Northeastern University
      Current Position: Clinical Pharmacotherapy Specialist - Hematology/Oncology, New York University Langone Health, New York, NY

      Patrick McBride, PharmD
      PGY-1 Training: Children's Hospital of Wisconsin, Milwaukee, WI     
      Education: MCPHS University, Boston, MA     
      Current Position: Oncology Clinical Pharmacist (Pediatrics), Dana-Farber Cancer Institute, Boston, MA

      Pain Management/Palliative Care

      Iman F. Suliman, PharmD
      PGY-1 Training: North Florida/South Georgia Veterans Health System    
      Education: University of Florida, Gainesville, FL     
      Current Position: Clinical Pharmacy Specialist-Palliative Care, Dana-Farber Cancer Institute, Boston, MA

      2016-2017

      Oncology

      Huong (Heather) Truong, PharmD, BCOP     
      PGY-1: Yale New Haven Health system, New Haven, CT    
      Education: University of Connecticut School of Pharmacy
      Current Position: Hematology/Oncology Pharmacist, Mayo Clinic, Rochester, MN

      Mary Nauffal, PharmD, MS     
      PGY-1: Brigham and Women's Hospital, Boston, MA     
      Education: Lebanese American University, Beirut, Lebanon     
      Current Position: Hematology/Oncology Clinical Pharmacy Specialist, Brigham and Women's Hospital, Boston, MA

      Pain Management/Palliative Care

      Benjamin S. Kematick, PharmD, BCACP
      PGY-1: University at Buffalo/Mobile Pharmacy Solutions, Buffalo, NY
      Education: University at Buffalo, Buffalo, NY
      Current Position: Clinical Pharmacy Specialist - Palliative Care, Dana-Farber Cancer Institute, Boston, MA

      2015-2016

      Oncology

      Jacob Barker, PharmD
      PGY-1: University of Michigan Health System, Ann Arbor, MI
      Education: University of New England School of Pharmacy, Portland, ME
      Current Position: Oncology Pharmacist Clinician, University of Vermont Medical Center, Burlington, VT

      Sydney Smith, PharmD, BCOP
      PGY-1: Cleveland Clinic, Cleveland, OH
      Education: Rosman University of Health Sciences, Henderson, NV
      Current Position: Stem Cell Transplant Clinical Pharmacist, Seattle Cancer Care Alliance, Seattle, WA

      2014-2015

      Oncology

      Doug Hackenyos, PharmD, BCOP     
      PGY-1: Tufts Medical Center, Boston, MA
      Education: MCPHS University, Worcester, MA
      Current Position: Clinical Pharmacy Specialist, Tufts New England Medical Center, Boston, MA

      Cynthia Herrera, PharmD, BCOP     
      PGY-1: Northwestern Memorial Hospital, Chicago, IL
      Education: Purdue University College of Pharmacy, West Lafayette, IN
      Current Position: Hematology/Oncology Clinical Pharmacist, Northwestern Medicine, Chicago, IL

      2013-2014

      Oncology

      Laura (Perry) Hackett, PharmD, BCOP     
      PGY-1: Dartmouth-Hitchcock Medical Center, Lebanon, NH
      Education: MCPHS University, Boston, MA
      Current Position: Hematology/Oncology Clinical Pharmacist, Dartmouth-Hitchcock Medical Center, Lebanon, NH

      Taylor Butler, PharmD, BCOP     
      PGY-1: Blount Memorial Hospital, Maryville, TN
      Education: University of Tennessee Health Science Center, Memphis and Knoxville, TN
      Current Position: Clinical Pharmacist, Tennessee Valley Veterans Affairs Health System, Nashville, TN

      2012-2013

      Oncology

      Amanda Dietzek, PharmD
      PGY-1: Einstein Medical Center, Philadelphia, PA
      Education: Northeastern University, Boston, MA
      Current Position: Oncology Clinical Pharmacy Manager, Einstein at Center One Pharmacy, Philadelphia, PA

      Kelly Connelly, PharmD, BCOP     
      PGY-1: Mount Sinai Medical Center, New York, NY
      Education: Duquesne University, Mylan School of Pharmacy, Pittsburgh, PA
      Current Position: Clinical Pharmacy Specialist, Johns Hopkins Hospital, Baltimore, MD

      2011-2012

      Oncology

      Kelley Carlstrom, PharmD, BCOP
      PGY-1: Beth Israel Deaconess Medical Center, Boston, MA
      Education: University of Colorado, Denver College of Pharmacy, Denver, CO
      Current Position: Clinical Oncology Consultant, iMethods, Jacksonville, FL

      2010-2011

      Oncology

      Meredith W. H. Higley, PharmD, BCPS, BCOP
      PGY-1: Parkview Health, Fort Wayne, IN
      Education: MCPHS University, Boston, MA
      Current Position: Coordinator, Oncology Pharmacy Services, Berkshire Medical Center, Pittsfield, MA

      2009-2010

      Oncology

      Houry Leblebjian, PharmD, BCOP
      PGY-1: UMass Memorial Medical Center, Worcester, MA
      Education: Lebanese American University, West Beirut, Lebanon
      Current Position: Clinical Pharmacy Practice Administrator, Dana-Farber Cancer Institute, Boston, MA

      2008-2009

      Oncology

      Jian Ni, PharmD
      PGY-1: West Virginia University Hospital, Morgantown, WV
      Education: MCPHS University, Boston, MA
      Current Position: Hematology/Oncology Pharmacy Specialist, Brigham and Women's Hospital, Boston, MA

      2007-2008

      Oncology

      Delila Katz, PharmD, BCOP
      PGY-1: Boston Medical Center, Boston, MA
      Current Position: Clinical Pharmacy Specialist, Palliative Care Oncology, UMass Memorial Medical Center, Worcester, MA

      2006-2007

      Oncology

      Victor Phantumvanit, PharmD, BCPS, BCOP
      PGY-1: Central Washington Hospital, Wenatchee, WA
      Education: University of Maryland, School of Pharmacy
      Current Position: Clinical Pharmacy Specialist, Dana-Farber Cancer Institute, Boston, MA

      2005-2006

      Oncology

      Gayle Blouin, PharmD, BCOP
      Education: MCPHS University, Boston, MA
      Current Position: Clinical Lead Pharmacist Ambulatory Oncology, Massachusetts General Hospital, Boston, MA

    • Applying for the Pharmacy Residency

      Eligibility

      Interested applicants must have a PharmD degree and successfully complete an ASHP-accredited PGY-1 pharmacy residency prior to anticipated start date. Candidate must also be eligible for licensure in the Commonwealth of Massachusetts.

      Application procedure

      Please submit your application through PhORCAS (Pharmacy Online Residency Centralized Application Service) — portal.phorcas.org — including:

      • Letter of intent
      • Curriculum vitae
      • Three letters of recommendation
      Application Deadlines

      Oncology: December 30, 2019
      Pain Management/Palliative Care and Medication-Use Safety: January 3, 2020
      Residency start date: First week in July